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Abstract 
Purpose: To isolate and characterize the membrane-active antimicrobial fraction and isolate metabolite 
produced by Streptomyces in soil samples from Iran  
Methods: More than 60 Actinomycete strains were isolated from soil samples in Iran. A total number of 
16 strains were studied using antimicrobial assay against Escherichia coli, Candida albicans and 
Staphylococcus aureus. Among these, three strains produced membrane-active metabolites based on 
artificial vesicle assay. Extracts of Streptomyces culture were obtained using ethyl acetate fractionation. 
Antimicrobial activity was evaluated by broth microdilution assay. Among these active extracts, one 
metabolite was isolated. Further fractionation and purification strategies were applied to finally identify 
the isolated metabolite using appropriate spectroscopic methods including thin layer chromatography 
(TLC), preparative thin-layer chromatography (PTLC), high performance liquid chromatography (HPLC), 
nuclear magnetic resonance (NMR) and liquid chromatography–mass spectrometry (LC-MS). 
Results: Three strains isolated from the soil samples, namely, strains 0811, 08346 and 08317 showed 
the highest antifungal and antimicrobial activity in Tryptic Soy Broth (TSB) and International 
Streptomyces Projects 2 (ISP2) medium in the range of 46.8 to 62.5 µg/ml. Strain 08346 was selected 
for further chemical profiling based on TLC pattern and membrane activity. It yielded a purified 
compound which was determined to be a novel aromatic amino alkyne, named Sourin. 
Conclusion: Streptomyces-produced 08346 strain demonstrates good antimicrobial activities against 
bacteria and yeasts, suggesting its potential as an antimicrobial membrane-active agent. 
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Microorganisms have been the most favorable 
resource of antibiotics in the past and will remain 
a main source of new bioactive natural products 
in the future. Almost 50 % of bioactive 
compounds are obtained from Actinomycetes [1]. 
 
Actinomycetes have high pharmacological 
interest and commercial value as they produce 
secondary metabolites with a diverse bioactivity. 
-----------------------------------------------------------------------------------------------------------------------------------------------------
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More than 7,600 compounds are produced by 
Streptomyces species [2]. Streptomycetes are 
known to be producers of many metabolites, 
possessing antibacterial, anti-parasitic, 
antifungal, immunosuppressive and antitumor 
properties [3]. Also, Actinomycetes are the major 
source of important antibiotics that are suitable in 
human and animal treatment, in industry and 
food production. Since they live in various soil 
habitats, soil ecology has been studied in various 
countries and also different surveys have been 
done in Iran [4-6]. 
 
The increase in frequency of resistance to 
antibiotics by pathogens represents a global 
health problem and therefore it is necessary to 
develop antibiotics with novel mechanisms of 
action [7,8]. Among the cellular targets for 
antibiotic action, membrane has great potential 
because of low tendency of developing 
resistance to it [9,10]. 
 
According to previous studies [11-13], lipid/PDA 
artificial vesicle model was successfully used for 
the screening of membrane active metabolites.  
As indicated earlier, out of 67 isolates, only 3 
(08-1-1, 08-3-17 and 08-34-6) showed potential 
membrane disruption activity and more 
researches have been performed to isolate and 
identify the metabolites existing in the fractions of 
the mentioned membrane active strain extracts. 
 
In this research, detection and purification of 
antimicrobial compound in the membrane-active 
fraction produced by Actinomycetes isolated from 
soil was accomplished by TLC and PTLC. 
Structure determination was performed by 






Organic solvents: hexane, chloroform, methanol 
and dimethyl sulfoxide were of analytic grade 
and ethanol was of HPLC grade, and obtained 
from Merck, Germany. Ethylacetate was 
obtained from Chem lab, Belgium. Silica gel TLC 
sheets were obtained from Merck, Darmstadt, 
Germany. Silica gel (200 - 400 mesh size) was 
obtained from Merck, Darmstadt, Germany.  
 
Sabouraud maltose broth was obtained from 
DIFCO, Becton, Dickinson, USA. Brain heart 
infusion (BHI) broth was obtained from Merck, 
Germany. Phospholipid, dimyristoyl phosphatidyl 
choline (DMPC), 10,12-tricocosadiynoic acid 
(TCDA) and diacetylenic monomer were 
purchased from Sigma, USA. 
 
Soil sample collection 
 
Since 2008, soil samples have been collected 
from several parts of northern and central Iran. 
These include the mineral soils around 
Meshkinshahr (38˚29.545״ N and 047˚44.886״ 
E), and desert soils around Damghan 
 E). The samples ״N and 053˚57.832 ״54.509˚35)
were taken from a depth of 15 cm from soil 
surface by a clean soil borer. The samples were 
placed in sterile bags, closed tightly and stored in 
a refrigerator as previously reported [11]. 
 
Extraction of antimicrobial metabolites 
 
The three isolated Streptomyces sp.: 0811, 
08346 and 08317 were grown in ISP4 medium 
plate and kept in an incubator for 5 - 7 days at 28 
°C. A loopful of spores was scraped from the 
plate and inoculated onto 3 mL ISP2 and TSB. It 
was kept in rotatory shaker incubator at 150 rpm 
for a period of 7 days at 28°C and used as 
inoculum. Culture inoculum was put in 2000 mL 
Erlenmeyer flasks containing 500 mL of ISP2 
and TSB then incubated at 25°C in a shaker at 
200 rpm for 14 days; after that, the culture broth 
was centrifuged at 4000 rpm for 15 min to 
remove the biomass. The culture medium was 
washed with ethyl acetate (1:3 v/v) and the ethyl 
acetate layer was removed after 30 min. The 
process was repeated thrice. The pooled ethyl 
acetate extract was distilled and dried in a rotary 
evaporator to obtain the final extract. 
 
Determination of minimum inhibitory 
concentration (MIC) 
 
MIC of the crude extracts produced by the 
isolated actinomycetes strains, against one Gram 
positive bacteria, one Gram negative bacteria 
and one fungus was determined by following the 
broth microdilution method of testing based on 
NCCLS M27-A [14]. 
 
Escherichia coli ATCC 25922, Candida albicans 
ATCC 10231 and Staphylococcus aureus ATCC: 
25923 were used as the test strains. The crude 
extracts were dissolved in dimethyl sulfoxide 
(DMSO) to obtain a concentration of 10 mg/mL.  
 
Sabouraud maltose broth was used as the 
growth medium and E. coli and S. aureus were 
cultured at 37°C for 24 h, in brain heart infusion 
broth (BHI). AmB was used as a positive control 
in the antifungal test, streptomycin for 
antimicrobial test and DMSO as solvent control. 
The plate was incubated at 37°C for 24 to 48 h. 
The MIC values are the lowest concentration of 
the extract showing no growth in the well. 
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Screening for antimicrobial membrane 
activity 
 
Artificial vesicle was applied using detection 
method, based on a biomimetic polymer 
polydiacetylene (PDA) together with phospholipid 
as a membrane model. To polymerize the vesicle 
components, synthetic phospholipid, dimyristoyl 
phosphatidyl choline (DMPC), and diacetylenic 
monomer, 10,12-tricocosadiynoic acid (TCDA), 
were separately dissolved in dichloromethane 1 
mg/mL, mixed at 2:3 molar ratio with a  total 
concentration of 1 mM. The lipid material was 
dried together in vacuum followed by addition of 
water and sonicated for 2 min. The solution was 
cooled, and kept overnight at 4°C, and then 
irradiated at 254 nm for one hour for 
polymerization. The resulting vesicle solution had 
intense blue color appearance due to 
polymerization of the diacetylene [16]. 
 
Circular dichroism (CD) spectroscopy 
 
The CD was performed on a Jasco 
spectropolarimeter model 810. The spectra were 
measured from 190 to 260 nm at room 
temperature and length cell was 1 mm. Data 
were recorded at a bandwidth of 1.5 nm and a 
step size of 1 nm with a scan rate of 200 nm/min. 
Data were reported as the accumulation of 
spectra for 3 consecutive recordings with 
concentrations of 1X, 1:5X, 1:250X and analyzed 
as mentioned in the result section [17]. 
 
Qualitative analysis by thin layer 
chromatography (TLC) 
 
In the current study, TLC and PTLC techniques 
were used to screen the ethyl acetate extracts of 
3 strains for secondary metabolites. Extracts 
were checked by TLC on analytical silica gel 
plates. Ethyl acetate extract was subjected to 
TLC in which different mobile phases like 
dichloromethane, chloroform and ethyl acetate/n-
hexane were tried in order to separate the 
bioactive compounds. After drying, the plates 
were visualized through UV at 254 and 366 nm in 
TLC viewer chamber. The compounds appeared 
on TLC plate in the form of bands. Each fraction 
can be further purified using PTLC and HPLC 
[18]. 
 
Purification of Sourin by preparative thin-
layer chromatography (PTLC) 
 
Slurry preparation for soft layer coating 
 
First, silica gel powder was dispersed in water to 
make a slurry, then the mixture was spread as a 
paste on a 20 x 20 cm glass plate. The resulting 
plate was dried and heated in an oven at 110°C 
for one hour in order to activate the silica gel 
layer. Silica gel 60, GF254 Merck, was used for 
PTLC. For each 1.0 mm silica layer, about 5 mg 
of the fraction was loaded. Mobile phases in 
varying proportions are n-hexane-ethyl acetate 
and chloroform-ethyl acetate.  The scraped 
bands were extracted with suitable solvent 
(methanol) and filtration as the final step was 
carried out to obtain the compound by removal of 




HPLC analysis were carried out with Perkin 
Elmer instrument (Flexar) equipped with a 
photodiode array detector (PDA) using a C18 
column (4.6 × 150 mm) Perkin Elmer. The 
column was equipped with a guard column C18 
(3.9 × 20 mm).  The PDA was used according to 
the following conditions: temperature: 25°C; 
pressure: 2500 psi; wavelength: 254 nm. The 
PDA provided all characteristic UV wavelengths. 
 
For analyses of the crude fraction, a standard 
HPLC method was set up with water (A), 
acetonitrile (B), gradient (100:0 to 0:100) with a 
total run time of 23 min. The flow rate of 1 ml/min 
was applied. The injection volume was 20 µL. 
Analysis of the pure fraction obtained from PTLC 
was carried out with the same HPLC condition 
using water (A), methanol (B), gradient (100:0 to 
0:100) as mobile phase. The peak of pure 
compound for each fraction was obtained and 
then analyzed by 1HNMR, 13CNMR, COSY and 
LC-MS.  
 
Characterization of the compound 
 
For characterization of the compound, 1HNMR, 
COSY and LC-mass spectra were performed. 
 
1H NMR, 13CNMR and COSY spectra were 
recorded on Bruker 300 MHz. The pure fractions 
were dissolved in solvent MeOD-d4, poured in 
NMR tube and observed on the applied magnetic 
field. All 1D and 2D spectra were obtained using 
the standard Bruker software.  
 
LC-MS was performed using Agilent 
Technologies 6410 Triple Quadrupole LC-MS, 
LC 1200 series. LC condition was set as follows: 
mobile phases A: water, B: acetonitrile. The flow 
was equal to 1 mL/min. Analysis program: The 
first 8 min was run with 20% B, for the next 3 min 
with 50% B; for the following 5 min with 100% B, 
and for the 7 last min with 20% B. The total run 
time was 23 min. Column was C18, (250 × 4.6 × 
5 mm), and the detector was photodiode array 
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(DAD) 254 nm, and injection volume was 20 µL. 




Statistical analysis was performed by averaging 
the antimicrobial assay. All results were repeated 
in duplicates and the average was obtained, and 
this analysis gave high reproducibility of MIC 




Isolated actinomycete strains and 
antimicrobial activity 
 
As previously mentioned, a total of 60 
Actinomycete strains were isolated from soil 
samples [12-14]. Among them, 16 strains 
showed antimicrobial activity and were effective 
against E. coli, C. albicans and S. aureus. The 
number of strains with membrane-active ethyl 
acetate extract that also showed good activity 
against the test microorganisms was three.  
 
The isolates are shown in Table 1. The results 
show that the selected strains produced 
metabolites present in ethyl acetate extract that 
inhibited the growth of bacteria and yeast in the 
assay. 
 
Optimized culture conditions 
 
According to previous report, the best duration 
for incubation is 14 days [12]. The suitable 
medium for the generation of bioactive 
compounds, ISP2 and TSB culture media, were 
used. According to the TLC and bioactivity 
results, strain 0811 (TSB) and 08346 (ISP2, 
TSB) were the best for generation of bioactive 
metabolites. TSB medium was the most 
appropriate one for the growth of all strains. 
 
PDA vesicles  
 
Membrane activity was measured by PDA 
vesicles. The color changes were generated by 
interaction of vesicle solution with membrane 
active metabolites present in the extract. The 
transition of blue to red was observed in the 
extract of strains 08346, 08317, 0811 in both 




Graphs produced by artificial membrane on CD 
spectroscopy show undesirable results with 1X, 
1:5X and 1:250X concentrations, hence, the 
tested concentration was changed to 1:2500X. 
Although, there was no significant difference 
among the CD graphs, in the absorbance section 
of the CD, the difference between the control 





HPLC generates a sensitive and rapid estimation 
of the profile for secondary metabolites present 
in ethyl acetate extracts. In Figure 1, the 
chromatographic profile of ethyl acetate for strain 
08346 (ISP2) performed by HPLC at 254 nm, is 
shown. 
 
Extensive LC-MS fragmentation experiments on 
the strain extract resulted in the molecular mass, 
to help in identification of metabolite and find the 
corresponding structure by NMR (Figure 2). 
 
Table 1: Antimicrobial activity of ethyl acetate fraction of actinomycete cultures against E. coli, S. aureus and C. 











24 h 48 h 24 h 48 h 24 h 
08-1-1/ ISP2 500 1000 >1000 >1000 >1000 
08-1-1/ TSB 500 1000 500 500 250 
08-3-17/ISP2 250 250 >1000 >1000 46.8 
08-3-17/ TSB 500 1000 1000 >1000 62.5 
08-34-6/ ISP2 125 1000 >1000 >1000 >1000 
08-34-6/ TSB 250 1000 1000 1000 >1000 
Ketoconazol 1.5 1.5 - - - 
AmB <0.78 0.78 - - - 
Streptomycin - - 6.25 6.25 50 
Kanamycin - - - - 25 
DMSO (v/v) 5% 10% >10% >10% 5% 
                (-) Not tested 
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Figure 1: Analysis of HPLC-PAD at 254 nm of the 





Figure 2: LC-MS chromatogram of crude ethyl acetate 
fraction from strain 08346/ ISP2. Top: MS detector 
(total ion count, TIC), bottom: diode array detector 
(DAD) 
 
Identified components of strains 
 
The best mobile phase for purification of strains 
was ethyl acetate/hexane 50:50. In this solvent 
system, TLC showed many metabolite spots that 
are produced by strain 08-34-6 according to their 
Rf values (0.22, 0.35 and 0.42). TLC in this 
solvent system showed clear spots with the 
mentioned Rf value for extracted 08346 strain. 
 
Ethyl acetate/hexane 50:50 mobile phase system 
was used for PTLC chromatography for the 
purification of compounds. One compound, PAF 
(named by our team as Sourin) was obtained 
from the bioactive fraction of strain 08-34-6. 
 
Purity of compounds  
 
Purity of the bioactive compounds was analyzed 
by HPLC and the chromatogram is shown in 
Figure 3. A sharp single peak was obtained at 
the retention time of 13.60 min with purity of 








The mass spectrum of the purified compound is 
shown in Figure 4. The purified PAF compound 
at positive ion mode and the ESI spectrum 
showed major (M + H) peak at 279 m/z. The 
calculated molecular mass of the purified 








1H NMR of the purified compound was obtained 
with 300 MHz instrument. From the 1H NMR 
spectra, the chemical shifts were observed and 
calculated with 4029 NS (number of scans). 
 
1HNMR (MeOD-d6, 300MHz) for PAF: 8.55 
(1H,s,H-OH), 7.80 (2H,d,H-3,3´), 7.49 (1H,d,H-
6), 7.17 (1H,d, H-5,7), 6.82 (1H, d, H-2,2’), 5.64 
(1H, s, NH-8), 4.67 (2H,t,H-9), 1.85 (3H,s,H-4), 
1.43 (2H,t,H-10), 1.30 (2H,s,H-11) and 1.16 
(3H,d,H-12).1H NMR (MeOD-d6, 300MHz).  
 
2D COSY results 
 
2D COSY experiments were performed in 
MeOD-d6 with 300 MHz NMR instrument. Inter 
molecular cross peaks between H-11 and H-12, 
H-9 and H-10, H-6 and H-5,7, and H-2,2’ and H-
3,3’ are shown in the contour plots of the COSY 
spectra of PAF. The 1H-1H COSY spectrum 
correlation amongst signals in the area of 7 ppm 
indicates the aromatic ring system for PAF.  
 
Inter-molecular cross peaks appear in the 
contour plots of COSY spectra and show cross 
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peaks between protons that are adjacent and 
interacting. 
 
These chemical assignments obtained from the 
UV, LC-ESI-MS and 1HNMR spectroscopy and 
COSY helped in the structure elucidation of 
compound PAF and hence the proposed 
structure is shown in Figure 5. The empirical 
formula of the purified compound was suggested 




Figure 5: Proposed structure of the compound 
isolated from strain 08-34-6 (PAF-Sourin). 
 
Based on the molecular weight obtained by the 
mass spectrum and search in databases like 
Resurrecting, Chemical Entities of Biological 
Interest, Super Natural database of natural 
products, massbank, BML-NMR and processing 
NMR spectra, it was confirmed that PAF is a new 
natural product. This report is the first to present 




Actinomycetes are usually dispersed in the 
environment and have the ability to produce 
several biologically active constituents like 
antiviral, antifungal, antibacterial and antitumor 
agents. Rahman et al. [19] examined twenty 
isolates out of 150 Actinomycetes that had 
antimicrobial activity. Arifuzzaman et al [20] 
investigated twenty isolates that showed activity 
against bacteria.  Also, Dehnad et al studied the 
bioactivity of Streptomyces isolates from Iran 
[21]. The current study was done to investigate 
the antimicrobial activity of Streptomyces isolated 
from soil and purify metabolite from it. The 
metabolite that was purified from the extract of 
soil Streptomyces was named Sourin and is one 
of the alkaloid-alkyne type compounds. The 
functional group characteristics and molecular 
mass of this molecule were confirmed by NMR 
and LC-MS techniques. This compound was 
isolated and purified from the membrane active 
ethyl acetate fraction. Similar compounds that 
showed multiple biological activities were 
reported by Minto and Blacklock [22].  Also, in 
another research, novel molecules with diverse 
antibacterial and antifungal activities were 
reported [23]. None of the reported compounds 
were associated with membrane disrupting 
activity. 
 
In other studies, successful application of PTLC 
and HPLC techniques were reported for the 
isolation and characterization of biologically 
active secondary metabolites from Streptomyces 
sample. TLC is a fast and easy procedure that 
gives a quick glimpse as to how many 
components could exist in a mixture [24]. 
Accordingly, CD had been used to monitor 





In the present study, there was effort to identify 
membrane active fraction and find Actinomycetes 
strains that exhibit activity against several 
opportunistic and microbial pathogens. The 
results indicate that it is possible to identify 
different soil living microorganisms that can 
produce membrane acting substances. Plasma 
membrane, as a new drug target, is important 
since most microorganisms can generate 
resistance to marketed antibiotics and membrane 
can act as a cellular target, which may not cause 
resistance to it. Structure determination of 
compounds in the active fractions is crucial to 
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